Affimed
AFMD
#10712
Rank
โ‚น0.28 B
Marketcap
โ‚น17.15
Share price
0.00%
Change (1 day)
10.35%
Change (1 year)

Earnings for Affimed (AFMD)

Earnings in 2024 (TTM): -โ‚น6.39 Billion

According to Affimed 's latest financial reports the company's current earnings are โ‚น0.96 Million. In 2023 the company made an earning of -โ‚น10.87 Billion a decrease over its 2022 earnings that were of -โ‚น8.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Affimed from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น6.39 Billion-41.27%
2023 -โ‚น10.87 Billion26.6%
2022 -โ‚น8.59 Billion36.51%
2021 -โ‚น6.29 Billion38.05%
2020 -โ‚น4.56 Billion33.51%
2019 -โ‚น3.42 Billion54.17%
2018 -โ‚น2.22 Billion-32.35%
2017 -โ‚น3.28 Billion-3.51%
2016 -โ‚น3.39 Billion60.24%
2015 -โ‚น2.12 Billion3296.68%
2014 -โ‚น62.27 Million-98.1%
2013 -โ‚น3.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
โ‚น7.92 B-209.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚น0.22 Billion-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น1.95 B-127.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.69 Billion 255.38%๐Ÿ‡บ๐Ÿ‡ธ USA